Covid-19 roundup: European vaccines lobby pushing for liability protection; VBI vaccines to prep human trials
With Covid-19 vaccine production moving at a breakneck pace, some in the industry are pushing for protections against potential lawsuits.
The European pharma industry’s vaccines lobby, Vaccines Europe, has been in discussions with the EU to create protections for its members should any problems arise with new coronavirus vaccines, according to a report from the Financial Times. Given that vaccine research can generally take years and the leading developers are already in Phase III studies, the lobby is advocating exemptions from civil liability.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 107,000+ biopharma pros reading Endpoints daily — and it's free.